|
|
|
Press Releases
All Releases
 |
HBIO Reports Third Quarter 2009 Revenue Growth of 5% Over Third Quarter 2008
Nov 4, 2009
|
36.4 KB |
|
| |
HOLLISTON, Mass., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today reported unaudited financial highlights for the three and nine months ended September 30, 2009.
Third Quarter Reported Results
Revenues fro...
|
|
Harvard Bioscience, Inc. Schedules Third Quarter 2009 Conference Call for November 4, 2009
Oct 23, 2009
|
10.6 KB |
|
| |
HOLLISTON, Mass., Oct. 23, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, will announce results for the third quarter ended September 30, 2009 after market trading hours on Wednesday, November 4, 2009.
A...
|
|
HBIO President David Green to Present At 2009 UBS Global Life Sciences Conference On September 23, 2009
Sep 10, 2009
|
8.3 KB |
|
| |
HOLLISTON, Mass., Sept. 10, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, today announced that its President, David Green, will present at the 2009 UBS Global Life Sciences Conference on Wednesday, Septemb...
|
|
HBIO Acquires Denville Scientific, Inc. -- A Well Established Supplier of Consumables for the Molecular Biology Market
Sep 3, 2009
|
13.1 KB |
|
| |
HOLLISTON, Mass., Sept. 3, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today announced that it has acquired the business of Denville Scientific, Inc. through a purchase of substantially all of Denville's assets and the ass...
|
|
HBIO Reports Second Quarter 2009 Results
Aug 6, 2009
|
39.5 KB |
|
| |
HOLLISTON, Mass., Aug. 6, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today reported unaudited financial highlights for the three and six months ended ...
|
|
Harvard Bioscience, Inc. Schedules Second Quarter 2009 Conference Call for August 6, 2009
Jul 21, 2009
|
9.6 KB |
|
| |
HOLLISTON, Mass., Jul 21, 2009 (GlobeNewswire via COMTEX) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, will announce results for the second quarter ended June 30, 2009 after market trading hours on Thursday, August 6, 2009....
|
|
Harvard Bioscience, Inc. Joins Russell 2000 Index
Jul 21, 2009
|
11.4 KB |
|
| |
HOLLISTON, Mass., July 21, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, today announced that on June 26, 2009 it was added t...
|
|
HBIO Reports First Quarter 2009 Results
Apr 30, 2009
|
42.1 KB |
|
| |
...
|
|
Harvard Bioscience, Inc. Schedules First Quarter 2009 Conference Call for April 30, 2009
Apr 16, 2009
|
10.8 KB |
|
| |
HOLLISTON, Mass.--(BUSINESS WIRE)--Apr. 16, 2009--
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce results for the
first quarter ended March 31, 2009 after market trading hours on
Thursday, April 30, 2009.
A conference call to discuss first quarter ended March 31, 2009
financial r...
|
|
Harvard Bioscience President David Green to Present at Cowen and Company 29th Annual Health Care Conference on March 17, 2009
Mar 10, 2009
|
10.9 KB |
|
| |
HOLLISTON, Mass., Mar 10, 2009 (BUSINESS WIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer,
manufacturer and marketer of a broad range of specialized products used
to advance life science research, today announced that its President,
David Green, will present at the Cowen and Company 29th
Annual...
|
|
HBIO Reports Fourth Quarter and Full Year 2008 Results
Feb 26, 2009
|
45.6 KB |
|
| |
...
|
|
Harvard Bioscience, Inc. Schedules Fourth Quarter 2008 Conference Call for February 26, 2009
Feb 9, 2009
|
12.7 KB |
|
| |
HOLLISTON, Mass.--(BUSINESS WIRE)--Feb. 9, 2009--
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce results for the
fourth quarter and year ended December 31, 2008 after market trading
hour...
|
|
HBIO Appoints McNaughton New CFO
Nov 14, 2008
|
11.7 KB |
|
| |
HOLLISTON, Mass., Nov 14, 2008 (BUSINESS WIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer,
manufacturer, and marketer of a broad range of tools to advance life
science research, today announced the hiring and appointment of Thomas
McNaughton as its new Chief Financial Officer effective immediately.
...
|
|
HBIO Reports Third Quarter 2008 Results
Nov 5, 2008
|
34.1 KB |
|
| |
HOLLISTON, Mass.--(BUSINESS WIRE)--Nov. 5, 2008--Harvard
Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and
marketer of a broad range of tools to advance life science research,
today reported unaudited financial highlights for the three and nine
months ended September 30, 2008.
Revenues from our continuing...
|
|
Harvard Bioscience, Inc. Schedules Third Quarter 2008 Conference Call for November 5, 2008
Oct 24, 2008
|
10.0 KB |
|
| |
HOLLISTON, Mass.--(BUSINESS WIRE)--Oct. 24, 2008--Harvard
Bioscience, Inc. (Nasdaq: HBIO) will announce results for the third
quarter ended September 30, 2008 after market trading hours on
Wednesday, November 5, 2008.
A quarterly conference call to discuss third quarter 2008
financial results will be held on Wednesday, November 5...
|
|
Harvard Bioscience President David Green to Present at 2008 UBS Global Life Sciences Conference on September 23, 2008
Sep 10, 2008
|
8.5 KB |
|
| |
HOLLISTON, Mass.--(BUSINESS WIRE)--Sept. 10, 2008--Harvard
Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and
marketer of a broad range of specialized products used to advance life
science research, today announced that its President, David Green,
will present at the 2008 UBS Global Life Sciences Conference on
Tuesday, Se...
|
|
HBIO Reports Second Quarter 2008 Revenue Growth of 13% Meets Q2 Guidance and Maintains 2008 Guidance
Aug 11, 2008
|
31.0 KB |
|
| |
HOLLISTON, Mass., Aug 11, 2008 (BUSINESS WIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer,
manufacturer, and marketer of a broad range of tools to advance life
science research, today reported unaudited financial highlights for
the three and six months ended June 30, 2008.
Revenues from our continuing operations for th...
|
|
Harvard Bioscience, Inc. Schedules Second Quarter 2008 Conference Call for August 11, 2008
Jul 24, 2008
|
10.0 KB |
|
| |
HOLLISTON, Mass., Jul 24, 2008 (BUSINESS WIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce results for the second quarter ended June 30, 2008 after market trading hours on
Monday, August 11, 2008.
A quarterly conference call to discuss second quarter 2008
financial results will be held on Monday, August 11, 2008 at 5:30 p...
|
|
HBIO Reports First Quarter 2008 Revenue Growth of 15%
May 1, 2008
|
27.5 KB |
|
| |
HOLLISTON, Mass., May 01, 2008 (BUSINESS WIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer,
manufacturer, and marketer of a broad range of tools to advance life
science research, today reported unaudited financial highlights for
the first quarter ended March 31, 2008.
First Quarter Reported Results
Revenu...
|
|
Harvard Bioscience Announces Resignation of Chief Financial Officer
Apr 25, 2008
|
8.8 KB |
|
| |
HOLLISTON, Mass.--(BUSINESS WIRE)--April 25, 2008--Harvard
Bioscience, Inc. (Nasdaq: HBIO), announced that on April 23, 2008,
Bryce Chicoyne resigned as its Chief Financial Officer. Mr. Chicoyne's
resignation is effective May 9, 2008. Mr. Chicoyne will continue to
work with us, assisting us with transitional matters and the
completion of ou...
|
|
|
=add release to Briefcase Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.
|
|
|
